Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · December 30, 2015

Prednisone vs Prednisone Plus Ciclosporin vs Prednisone Plus Methotrexate in New-Onset Juvenile Dermatomyositis

The Lancet


Additional Info

The Lancet
Prednisone Versus Prednisone Plus Ciclosporin Versus Prednisone Plus Methotrexate in New-Onset Juvenile Dermatomyositis: A Randomised Trial
Lancet 2015 Nov 29;[EPub Ahead of Print], N Ruperto, A Pistorio, S Oliveira, F Zulian, R Cuttica, A Ravelli, M Fischbach, B Magnusson, G Sterba, T Avcin, K Brochard, F Corona, F Dressler, V Gerloni, MT Apaz, C Bracaglia, A Cespedes-Cruz, R Cimaz, G Couillault, R Joos, P Quartier, R Russo, M Tardieu, N Wulffraat, B Bica, P Dolezalova, V Ferriani, B Flato, AG Bernard-Medina, T Herlin, M Trachana, A Meini, E Allain-Launay, C Pilkington, V Vargova, C Wouters, S Angioloni, A Martini

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading